Telemedicine in the treatment of gestational diabetes: An observational cohort study on pregnancy outcomes and maternal satisfaction.

diabetes eHealth gestational diabetes pregnancy-induced telehealth

Journal

Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858

Informations de publication

Date de publication:
29 Aug 2023
Historique:
revised: 08 08 2023
received: 23 11 2022
accepted: 09 08 2023
pubmed: 30 8 2023
medline: 30 8 2023
entrez: 29 8 2023
Statut: aheadofprint

Résumé

Gestational diabetes treatment requires several outpatient consultations from diagnosis until delivery in order to prevent hyperglycaemia, which is associated with maternal and fetal complications. There is limited evidence in the literature about telemedicine superiority in improving pregnancy outcomes for women with gestational diabetes. The primary aim of the study was to evaluate maternal and fetal outcomes, while the secondary aim was to estimate the degree of satisfaction with gestational diabetes treatment, comparing telemedicine versus outpatient care. This observational cohort study involved 60 consecutive women with gestational diabetes treated at the Diabetology Unit of Ferrara: 27 were followed up through a weekly remote control method (telemedicine group) and 33 in ambulatory clinics every 2 or 3 weeks (conventional group). After giving birth, 56 women responded to the modified Oxford Maternity Diabetes Treatment Satisfaction Questionnaire to assess their satisfaction with diabetes care. No statistically significant differences were found in most of the maternal and neonatal parameters evaluated in both groups. The questionnaire scores were positive in all areas investigated. Telemedicine follow-up made women feel more controlled (p = 0.045) and fit better with their lifestyle (p = 0.005). It also emerged that almost all women treated with telemedicine would recommend this method to a relative or a friend. Telemedicine follow-up proved to be safe both in terms of metabolic control and pregnancy outcomes; furthermore, it significantly decreased the need for outpatient consultations and increased women's satisfaction. Studying the impact of telemedicine is also necessary, considering the current difficulties associated with the Sars-COV-2 pandemic.

Identifiants

pubmed: 37643876
doi: 10.1111/dme.15201
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15201

Informations de copyright

© 2023 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.

Références

American Diabetes Association Professional Practice Committee. Standards of medical care In diabetes-2022. Diabetes Care. 2022;45(Suppl1):S17-S38;S232-S243. doi:10.2337/dc22-S002
HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991-2002. doi:10.1056/NEJMoa0707943
ACOG Practice Bulletin No 190. Summary: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):406-408. doi:10.1097/AOG.0000000000002498
Lowe WL Jr, Scholtens DM, Kuang A, et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care. 2019;42(3):372-380. doi:10.2337/dc18-1646
Kelley KW, Carroll DG, Meyer A. A review of current treatment strategies for gestational diabetes mellitus. Drugs Context. 2015;4:212282. doi:10.7573/dic.212282
Walker JD. NICE guidance on diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE clinical guideline 63. London Diabet Med. 2008;25(9):1025-1027. doi:10.1111/j.1464-5491.2008.02532.x
NICE Guideline, No. 3. Diabetes in pregnancy: management from preconception to the postnatal period. National Institute for Health and Care Excellence (NICE); 2020.
Sood S, Mbarika V, Jugoo S, et al. What is telemedicine? A collection of 104 peer-reviewed perspectives and theoretical underpinnings. Telemed J E Health. 2007;13(5):573-590. doi:10.1089/tmj.2006.0073
Mastrogiannis DS, Igwe E, Homko CJ. The role of telemedicine in the management of the pregnancy complicated by diabetes. Curr Diab Rep. 2013;13(1):1-5. doi:10.1007/s11892-012-0352-x
Fantinelli S, Marchetti D, Verrocchio MC, Franzago M, Fulcheri M, Vitacolonna E. Assessment of psychological dimensions in telemedicine care for gestational diabetes mellitus: a systematic review of qualitative and quantitative studies. Front Psychol. 2019;10:153. doi:10.3389/fpsyg.2019.00153
Ming WK, Mackillop LH, Farmer AJ, et al. Telemedicine technologies for diabetes in pregnancy: a systematic review and meta-analysis. J Med Internet Res. 2016;18(11):e290. doi:10.2196/jmir.6556
Xie W, Dai P, Qin Y, Wu M, Yang B, Yu X. Effectiveness of telemedicine for pregnant women with gestational diabetes mellitus: an updated meta-analysis of 32 randomized controlled trials with trial sequential analysis. BMC Pregnancy Childbirth. 2020;20(1):198. doi:10.1186/s12884-020-02892-1
Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297. doi:10.1371/journal.pmed.0040297
Hirst JE, Mackillop L, Loerup L, et al. Acceptability and user satisfaction of a smartphone-based, interactive blood glucose management system in women with gestational diabetes mellitus. J Diabetes Sci Technol. 2015;9(1):111-115. doi:10.1177/1932296814556506
Bertino E, Spada E, Occhi L, et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr. 2010;51(3):353-361. doi:10.1097/MPG.0b013e3181da213e
Raman P, Shepherd E, Dowswell T, Middleton P, Crowther CA. Different methods and settings for glucose monitoring for gestational diabetes during pregnancy. Cochrane Database Syst Rev. 2017;10(10):CD011069. doi:10.1002/14651858.CD011069.pub2
Dalfrà MG, Nicolucci A, Lapolla A, TISG. The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. J Telemed Telecare. 2009;15(5):238-242. doi:10.1258/jtt.2009.081213
Bertini A, Gárate B, Pardo F, et al. Impact of remote monitoring technologies for assisting patients with gestational diabetes mellitus: a systematic review. Front Bioeng Biotechnol. 2022;10:819697. doi:10.3389/fbioe.2022.819697

Auteurs

Sara Montori (S)

Department of Medical Sciences, Section of Obstetrics and Gynecology, S. Anna University Hospital, University of Ferrara, Ferrara, Italy.

Francesca Lugli (F)

Complex Operational Unit Territorial Diabetology, AUSL of Ferrara, Ferrara, Italy.

Marcello Monesi (M)

Complex Operational Unit Territorial Diabetology, AUSL of Ferrara, Ferrara, Italy.

Gennaro Scutiero (G)

Department of Medical Sciences, Section of Obstetrics and Gynecology, S. Anna University Hospital, University of Ferrara, Ferrara, Italy.

Elena Forini (E)

Unit of Statistics, S. Anna University Hospital of Ferrara, University of Ferrara, Ferrara, Italy.

Pantaleo Greco (P)

Department of Medical Sciences, Section of Obstetrics and Gynecology, S. Anna University Hospital, University of Ferrara, Ferrara, Italy.

Rosita Verteramo (R)

Department of Medical Sciences, Section of Obstetrics and Gynecology, S. Anna University Hospital, University of Ferrara, Ferrara, Italy.

Classifications MeSH